Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI Names Discovery SVP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

AMRI Names Discovery SVP

Luther brings extensive discovery experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Michael A. Luther, Ph.D., has been appointed senior vice president of Discovery at AMRI, effective October 28, 2013. Dr. Luther will report to Thomas E. D’Ambra, Ph.D., president and chief executive officer. Dr. Luther succeeds Bruce J. Sargent, Ph.D., who will retire at the end of the year.
 
Dr. Luther will lead the company’s global discovery organization, which provides biology and chemistry services to the biopharmaceutical industry, with locations in the U.S., Singapore and Hyderabad, India. Dr. Luther will also oversee AMRI’s expansion into Western New York in the Buffalo Medical Innovation and Commercialization Hub at Buffalo Niagara Medical Campus.
 
Dr. Luther most recently served as corporate vice president of Global Discovery Research Services at Charles River Laboratories, where he managed the discovery business unit, including developing and implementing strategic and operating plans. Prior to Charles River, he was president and a member of the board of directors of the David H. Murdock Research Institute in Kannapolis, NC, where he led and directed R&D activities from discovery to proof of principle and early product development. He also held roles as vice president and site head at Merck Frosst in Montreal, and vice president, High Throughput Biology at GlaxoSmithKline.
 
“We are pleased and excited Dr. Luther is joining AMRI’s leadership team as we continue to execute our growth strategy and move forward providing high quality services to the pharmaceutical and biotechnology industries,” said Dr. D’Ambra. “Mike’s strong biology background and accomplishment, as well as his experience in both large pharma and the CRO world bring to his role the experience and network to strengthen AMRI’s position as a leading discovery partner to the industry. I am confident that Dr. Luther is the right person to lead AMRI’s strong global discovery brand to the next level as we expand the breadth and depth of our biology capabilities in line with movement by our customers seeking greater and more integrated offerings by service providers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics